CT
Contineum Therapeutics, Inc. (CTNM)
NASDAQ·Healthcare·Biotechnology
$12.55
-6.34%
Mkt Cap $509.01M
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (9 analysts)
$16.00
Range $16.00 – $16.00
Implied Upside
+27.5%
Consensus $16.00 vs current $12.55
NASDAQ·Healthcare·Biotechnology
$12.55
-6.34%
Mkt Cap $509.01M
Buy
3
Hold
1
Sell
0
Price Target (9 analysts)
$16.00
Range $16.00 – $16.00
+27.5%
Consensus $16.00 vs current $12.55